                </a></li></ul></div><p><strong>Figure 5.  <span>A combination of <sup>225</sup>Ac-E4G10 with paclitaxel enhances the anti-tumor response.</span></strong></p><a id="article1.body1.sec3.sec5.fig1.caption1.p1" name="article1.body1.sec3.sec5.fig1.caption1.p1"></a><p>A, Tumor volume in the four treatment groups over time. Data are mean Â± S.E.M. B, Kaplan Meier survival curve of treated animals showing significant enhancement of animal survival when <sup>225</sup>Ac-E4G10 therapy is followed by a course of paclitaxel. C, Absence of histopathologic damage in normal organs, assessed 10 days after cessation of <sup>225</sup>Ac-E4G10 treatment.</p>
<span>THISISTHEEND
